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PAST
Inguinal lymphadenectomy is the current standard of
care in the management of macroscopic nodal disease, but
unfortunately postoperative complications are very com-
mon, especially seroma. Seroma rates from the published
literature are, on average, approximately 50%.1 Multiple
studies have investigated interventions designed to either
reduce the incidence or reduce the extent of the problem
once it has become established. A recent systematic review
by the Cochrane Group2 identified a lack of any useful data
and concluded that ‘‘… there is a need for high-quality
randomized controlled trials to guide clinical practice in
this under-researched area’’. Seromas are important
because they affect patients’ quality of life postoperatively,
invariably cause patients to return repeatedly to the clinic
over a period of many weeks for aspirations, and subse-
quent complications such as infection are common as a
result.
PRESENT
In this retrospective study,3 we employed a two-layer
negative pressure wound therapy system (2-LNPWT) as a
method to reduce seroma rates and perioperative compli-
cations. We compared the outcomes of its use with
traditional closed suction drains (CSDs). The key finding of
this study was that there was a significant association with
better postoperative outcomes using the 2-LNPWPT sys-
tem in terms of incidence of seroma formation (26.9% vs.
49.4%; odds ratio [OR] 3.0; p\ 0.03), period of drainage
(15 days vs. 20 days; p = 0.005), and return to theater rate
(0% vs. 15.3%; p = 0.03). When the factors for seroma
formation were analyzed, the only significant association
was the type of drainage system used (2-LNPWT: 31.2%
vs. CSD: 58.3%; p\ 0.03; OR 3.0 [1.1–8.3]). Further-
more, once a seroma was established, it was not possible to
alter the clinical course of this complication, regardless of
the drainage system that was originally employed. Finally,
there was no significant difference in overall, disease-
specific, or recurrence-free survival detected between the
two groups.
FUTURE
This study3 has provided evidence that the incidence of
seroma, and subsequent complications, can be significantly
reduced with a 2-LNPWT system, regardless of disease
burden or patient body mass index. Importantly, the data
suggest that this is a safe technique in terms of disease-
specific outcomes, despite previous theoretical concerns
regarding promotion of tumor angiogenesis at the operation
site.
The data indicate that a prospective randomized con-
trolled trial is merited, with expansion to include other
disease indications, particularly urological and gynaeco-
logical tumors. The utility of the technique in previously
irradiated wounds would be of particular interest, although
one would assume that the efficacy would be significantly
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diminished in these cases. With the current vogue towards
endoscopic groin dissections,4 the technique would need
further modification. In any case, given the relative ‘Heath
Robinson’ design to our system, we would encourage the
commercial sector to invest in product design to improve
the facility for applying and changing the dressings in both
the hospital and primary care settings.
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